Back to Journals » Research and Reports in Tropical Medicine » Volume 12

Human Toxocariasis: 2010 to 2020 Contributions from Brazilian Researchers

Authors Chieffi PP , Zevallos Lescano SA , Rodrigues e Fonseca G, Santos SV

Received 27 February 2021

Accepted for publication 26 April 2021

Published 19 May 2021 Volume 2021:12 Pages 81—91

DOI https://doi.org/10.2147/RRTM.S274733

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Mario Rodriguez-Perez



Pedro Paulo Chieffi,1 Susana Angelica Zevallos Lescano,2 Gabriela Rodrigues e Fonseca,3 Sergio Vieira dos Santos1

1Department of Pathological Sciences, Santa Casa Medical School, São Paulo, Brazil; 2Laboratory of Helminthology, Institute for Tropical Medicine of São Paulo, University of São Paulo, São Paulo, Brazil; 3Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo, Brazil

Correspondence: Pedro Paulo Chieffi
Departamento de Ciências Patológicas, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Cesário Mota Junior, 112, São Paulo, CEP01221-020, Brasil
Tel +5511-33677722
Email [email protected]

Abstract: This is a review of the published contributions made by Brazilian researchers between 2010 and 2020 on the natural history of human toxocariasis and the effects of human toxocariasis on nonhuman paratenic hosts.

Keywords: Toxocara, Toxocara canis, toxocariasis, visceral larva migrans syndrome, Brazilian contribution

Introduction

Human toxocariasis, first described in 1952 by Beaver et al,1 is currently considered an important zoonosis and the main cause of visceral larva migrans (VLM) and other syndromes, such as ocular larva migrans (OLM), covert toxocariasis (CT), and neurological toxocariasis.2–5 Signs and symptoms of the main clinical types of human toxocariasis are6–8

Visceral Larva Migrans – fever, pallor, malaise, irritability, weight loss, cutaneous rash, hepatomegaly, respiratory and nervous disturbs, myocarditis, hypergammaglobulinemia, leukocytosis and eosinophilia, elevated anti-A and anti-B isohemagglutinins; Ocular Larva Migrans – visual loss, strabismus, retinal granuloma and detachment, endophthalmitis, chorioretinitis, uveitis; Covert Toxocariasis – coughing, abdominal pain, headache, sleep and behavioral disturbances.

An analysis of the published toxocariasis research from 1932 to 2015 showed that researchers from the United States of America and Japan were responsible for 18.5% of a total of 2765 papers identified in the Scopus database, followed by researchers from Brazil and the United Kingdom, each responsible for 6.5% of the published papers.9

In 2009, Chieffi et al10 published a paper reviewing the contributions of Brazilian researchers to the main aspects of the natural history of human toxocariasis. The aim of this current paper is to update the Brazilian contributions on the natural history from 2010 to 2020. The MEDLINE and LILACS databases were used and representative articles consisting of papers published by Brazilian researchers were selected.

Toxocara canis Infection in Dogs and Soil Contamination by Toxocara Eggs

Dogs and other canids are the natural hosts of Toxocara canis; they can be infected via several routes; however, the transplacental and transmammary migration of third-stage larva are the principal mechanisms leading to the maintenance of high levels of infection in young dogs.11 Under certain conditions, T. canis can infect cats and develop into adult worms. Additionally, T. cati can infect dogs.12 In humans, with few exceptions, Toxocara infections lead to the presence and migration of larvae, which remain in the third developmental stage.

Stray dogs are usually controlled in the urban areas of Brazil; however, control does not necessarily extend to many suburban or rural localities, where stray dogs are not dewormed, which thus negatively impacts public health.

The most important route for human infection is the accidental ingestion of the embryonated eggs of Toxocara. The prevalence of T. canis infections in dogs, therefore, as reflected by soil contaminated by ascarid eggs, should be considered a good index of the risk of human infection by Toxocara larvae. Chieffi et al10 previously referred to parasitological soil surveys conducted in several Brazilian locations, which showed huge variations in the rates of T. canis infections in dogs, ranging from 5.5% to 39%.

Some publications from 2010 to 2020 by Brazilian researchers reported on the rates of T. canis infection in dogs and confirmed the rates that had already been established.13–15 However, a serological investigation in Salvador (Bahia State) revealed that 82.7% of 301 dogs were positive for anti-Toxocara IgG antibodies.16 On the other hand, Merigueti et al17 examined 165 dogs at a veterinary hospital and found T. canis eggs in 6.7% of samples of dog hair that were mainly collected in or near the dog tail.

Several Brazilian researchers investigated the soils of public spaces for Toxocara eggs between 2010 and 2020 (Table 1) and almost always found high positivity rates.18–25 Santarém et al19 found higher numbers of Toxocara eggs in the soil of public parks with mean monthly temperatures and monthly amounts of rainfall. Queiroz et al26 had also noticed increased soil contamination at a similar time.

Table 1 Soil Contamination by Toxocara Eggs in Public Places in Brazilian Locations, from 2010 to 2020

Frequency and Characteristics of Human Infections Due to Toxocara

Researchers aiming to assess the frequency of human Toxocara infections in Brazil began to emerge in the late 1980s. The main serological surveys carrying out this aim up to 2009 have been summarized elsewhere.10 Tables 2 and 3 summarize the rates of infection in adults and in children. The tables reveal broad variations in infection rates, but highlight the importance of the morbidity of Toxocara infections in humans, especially children, and mainly is those aged from 1 to 8 years.27

Table 2 Percentage of Human Seropositivity by Toxocara in Adults in Some Brazilian Regions

Table 3 Percentage of Human Seropositivity by Toxocara in Children in Some Brazilian Regions, Tested by ELISA

It is important to note, however, the scarcity of surveys based on samples that are statistically representative of the population being investigated, which perhaps accounts for the varying rates that have been sometimes found in the same regions or from areas nearby.

Figures 1 and 2 show the geographical location in Brazil of positive tests for antiToxocara antibodies in adults and children, examined by ELISA.

Figure 1 Geographical distribution in Brazil of anti-Toxocara antibodies in adults examined by ELISA from 2010 to 2020.

Figure 2 Geographical distribution in Brazil of anti-Toxocara antibodies in children examined by ELISA from 2010 to 2020.

In Rio Grande in Southern Brazil, 8% of 200 pregnant women were found to be coinfected with Toxocara canis and Toxoplasma gondii. This coinfection was associated with neonates with low birth weights.48,49

Frequent contact with soil or with dogs and cats has been identified as a risk for human Toxocara infection, especially in children.18,29,31,33,36,40 According to Colli et al,27 contact with the soils of recreational areas of schools is a higher risk of Toxocara infection in children than frequent contact with the soils of public squares.

Mattos et al50 performed an interesting study that determined the prevalence of infection and risk factors of infection in researchers who worked frequently with Toxocara in the laboratory. The control group consisted of researchers without contact with Toxocara in their laboratory activities. They found that the group working with Toxocara showed a lower frequency of infection compared to the controls (13.8% vs 15.6%, respectively), indicating that the Toxocara researchers, possibly because they were taking special precautions, were less exposed to the risk of Toxocara infection than the controls.

Changes in liver and pulmonary parameters are frequent in human toxocariasis, mainly in children. Although less frequent, ocular and brain lesions and allergic manifestations can occur.51 Carvalho et al52 used abdominal ultrasound to reveal hepatic changes such as hypoechoic liver lesions and/or enlarged lymph nodes in 29.7% of 37 children with toxocariasis.

The relevance of allergic manifestations in patients with toxocariasis is controversial among Brazilian researchers. Zaia et al53 observed acute allergic inflammation of the airways of mice infected by T. canis. Silva et al54 reported a patient with Loeffler syndrome who had been infected by T. canis. The patient only showed marked improvement after treatment with thiabendazole. On the other hand, Grama et al55 and Cadore et al56 did not find an association between atopy and an increased risk of asthmatic manifestations in children with serological tests positive for anti-Toxocara antibodies. In 2012, Mendonça et al51 did not find an association between positivity for aeroallergens and Toxocara infections in children living in poor areas of Salvador (Bahia State) and postulated that increased polyclonal IgE levels and the induction of a modified Th2 immune response to Toxocara infection might prevent the development of skin hypersensitivity to aeroallergens. On the other hand, Fialho and Corrêa57 found an association between asthma and increased body mass index in children and adolescents living in Campinas (São Paulo State), and Fialho et al58,59 confirmed a positive association between urticaria and infection with Toxocara in children.

Recuero et al60 described a case of eosinophilic panniculitis as a rare skin manifestation associated with toxocariasis in a 5-year-old girl with an ELISA positive for Toxocara. Albendazole treatment (10 mg/kg/day for 10 days) provided complete resolution of her condition. Another uncommon complication of toxocariasis in a child was reported by Salvador et al,61 who described the concomitant involvement of the cerebrum, cerebellum, and the peripheral nervous system of a 5-year-old boy from Porto Alegre (Rio Grande do Sul State).

Acute joint manifestations are common in toxocariasis; however, chronic polyarthritis as an isolated manifestation is very uncommon. Viola et al62 reported the case of a 3-year-old girl with chronic severe, painful polyarthritis and 30 min of morning stiffness that lasted longer than 10 weeks. The patient was positive for anti-Toxocara antibodies on ELISA. Treatment with paracetamol and thiabendazole for 10 days led to reduction in all the clinical manifestations of the infection.

Laboratory Diagnosis of Human Toxocariasis and Toxocariasis in Other Paratenic Hosts

Parasitologists usually prefer to diagnose parasitic infections by demonstrating the presence of the parasite in the host organism. The diagnosis of human toxocariasis is only possible through a biopsy, which is both extremely invasive and is sometimes neither safe nor accurate. The use of immunohistochemical techniques, in turn, allows identification of Toxocara antigen expression in histological sections.63 However, because biopsies are invasive, they are not common, and indirect diagnostic techniques are therefore more common.

Traditional indirect laboratory methods employed for the diagnosis of human toxocariasis rely usually on enzyme-linked immunosorbent assays (ELISAs) and Western blots. However, the production of T. canis antigens for use in those evaluations is arduous and time-consuming, taking at least 60 days,64 and does not eliminate possible cross-reactions with other similar antigens of other intestinal parasites.65 Several Brazilian researchers tried to resolve the shortcomings of the methods used in the diagnosis of human toxocariasis during the period from 2010 to 2020.

In an attempt to improve the sensitivity and specificity of immunological tests for the diagnosis of human toxocariasis, several researchers sought to identify possible markers of infections and the immunodominant antigens of T. canis.64,66–70

Roldán et al71 showed that IgM antibodies used for the serodiagnosis of human toxocariasis showed low specificity, and Santos et al72 found that Toxocara recombinant antigens developed with the use of the yeast Pichia pastoris instead of Escherichia coli showed low sensitivity for the immunodiagnosis of Toxocara infections. On the other hand, when Santos et al73 previously used recombinant antigens of low molecular weight (30 kDa), they obtained better results, especially in surveys that included children.

Some researchers have dedicated themselves to the study of the somatic and surface proteins of T. canis. They have obtained results that, in addition to contributing to the improvement of immunological tests, have provided information that allows the development of potential vaccines.74,75

The laboratory diagnosis of human ocular toxocariasis represents a greater challenge than the diagnosis of the visceral form because the levels of serum antibodies in the host are usually low and sometimes undetectable.76,77 Imaging modalities such as ultrasonography or optical coherence tomography should be useful additions to the clinical examination of patients suspected to have ocular toxocariasis.78,79 However, if ocular toxocariasis is suspected, despite the risks, an assessment of specimens of the aqueous or vitreous humor is recommended.

Aspects of the immune response of nonhuman paratenic hosts, with possible benefits for surveys aimed at determining the frequency of infections by Toxocara larvae, have been studied in vivo, in mouse or rabbit models.80–90 Serological surveys carried out on synanthropic animals that are paratenic hosts of T. canis revealed significant natural frequencies of infection, indicating that there is a risk involved in the human consumption of raw or undercooked meat from these animals.91–94 Recombinant proteins used in ELISAs and Western blot assays for the diagnosis of Toxocara infections of cattle, horses, and sheep have obtained good results.95

Treatment and Prophylaxis of Human Toxocariasis

Although the anthelminthic treatment of dogs with patent intestinal infections of T. canis shows good results; the anthelminthic treatment of Toxocara larvae encysted in canine tissues has been ineffective.6 In human toxocariasis, ascarid larvae migrate or encyst in tissues; thus, the use of various anthelmintics such as diethylcarbamazine and benznidazole derivatives has not led to the complete elimination of encysted larvae but has usually reduced or controlled the symptoms of those infections.96

Some Brazilian researchers also have tested anthelmintics in rodents infected by T. canis. Lescano et al97 compared the effect of nitazoxanide, a drug recently used for the treatment of several human protozoal and helminthic infections, with mebendazole, a benznidazole derivative known to reduce the Toxocara larval load in experimental rodent infections. They found a greater reduction in the number of larvae in the rodents treated with mebendazole than in those treated with nitazoxanide.

Another group of researchers tested the effects of quinone derivatives against Toxocara larvae in vitro, as well as their anthelmintic action in experimental rodent infections.98,99 They found good in vitro larvicidal activity and an anthelmintic activity similar to that found with benznidazole derivatives. Sinott et al,100 in turn, reported that the essential oil extracted from Brazilian red propolis showed good Toxocara larvicidal activity. On the other hand, Avila et al101 showed an increase in the larval burden of Toxocara in mice treated with cyclophosphamide or dexamethasone, drugs commonly used in immunosuppressive treatments.

Probiotics have recently been studied by some researchers, including researchers in Brazil, as possible alternatives for the control or even treatment of human toxocariasis.64 Avila et al102 found a significant reduction in the burden of Toxocara larvae in mice that were treated with Saccharomyces boulardii for 15 days. However, in a subsequent in vitro experiment they noticed a lack of action by S. boulardii on T. canis larvae in vitro, indicating that an interaction with the intestinal mucosa is mandatory for the protective effect of S. boulardii.103 The same researchers postulated that this type of protection could be provided through the modulation of cytokine expression, especially IL-12104,105 Walcher et al106 found that the probiotic Lactobacillus rhamnosus showed protective results similar to those provided by S. boulardii.

Another line of investigation, which is focused on the prophylaxis of toxocariasis, is the possible deleterious effects of some fungi on Toxocara eggs. Thus, the in vitro studies of the fungus Pochonia chlamydosporia showed its deleterious effects on T. canis and T. vitulorum eggs.107–109 Other species of fungi in the Trichoderma and Fusarium genera also showed deleterious in vitro activity against Toxocara eggs.110,111

Verocai et al112 showed that Toxocara eggs were resistant to solutions of sodium hypochlorite, benzalkonium chloride, and formaldehyde-based disinfectants. However, 70% ethanol led to the complete degeneration of Toxocara eggs in a few days.

Some researchers have focused on the use of synanthropic animals such as chickens as sentinels for soil contaminated by Toxocara eggs.113,114

Experimental Studies in Nonhuman Paratenic Hosts

Several researchers have focused on the roles and importance of the vertical and transmammary transmission of T. canis. Schoenardie et al41 verified the vertical transmission of T. canis in mice either with chronic infections or infections during the acute phase. The importance of the transmammary route in the transmission of T. canis in mice was emphasized by a group of researchers from the Federal University of Rio Grande, in the state of Rio Grande do Sul.115,116

The migration patterns of T. canis were studied in experimental infections of mice and gerbils. In Rattus norvegicus, a significant difference was found between the migration patterns according to the sex of the animals. Female rats showed a greater number of larvae in the liver than males.117 Resende et al82 studied the immunopathology of T. canis infections in mice and found similar larval migration patterns, with innate induction of TH17/TH2 responses during early infection. The migration patterns of T. canis larvae in the gerbil Meriones unguiculatus were similar to the patterns already observed in mice and rats; however, in reinfected animals, more larvae were apparently retained within hepatic granulomas, without evident signs of destruction.118

There are numerous references in the literature on behavioral changes in rodents experimentally infected with T. canis, which are associated with larvae located in the central nervous system.119,120 Before reaching the nervous system, the larvae pass through muscle tissues, being able to determine alterations.7 Santos et al121 observed a decrease in the strength of the muscles of rats (R. norvegicus) infected with T. canis or T. cati. The reduction in muscle strength was greater in rats infected with T. cati than in rats infected with T. canis. Researchers from the same group26,122 studied the patterns of behavioral changes in mice and rats concomitantly infected with T. canis and Toxoplasma gondii and observed that the obvious changes that occurred in animals infected with T. canis only or T. gondii only were not manifested in mice and rats with concomitant infections of both parasites.

The hamster (Mesocricetus auratus) is another species of rodent that is frequently used in the laboratory. It has been characterized by histopathological, immunohistochemical, and immunoelectron microscopic findings as a good animal model for research on toxocariasis.123

Conclusions

Evidence on the occurrence of human toxocariasis in Brazil indicates that additional well designed and comprehensive epidemiological studies are needed. The studies should be applied to the entire nation in order to understand the spatial distribution of this zoonosis and provide reliable information for implementing a national program to control it.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Beaver PC, Snyder H, Carrera G, Dent J, Lafferty I. Chronic eosinophilia due to visceral larva migrans. Pediatrics. 1952;9:7–19.

2. Taylor MRH, Keane CT, O’Connor P, Girdwood RW, Smith H. Clinical features of covert toxocariasis. Scand J Infect Dis. 1987;19:696–699. doi:10.3109/00365548709117206

3. Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104:3–23. doi:10.1179/136485910x12607012373957

4. Torgerson PR, Macpherson CNL. The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol. 2011;182:79–95. doi:10.1016/j.vetpar.2011.07.017

5. Fialho PM, Corrêa CR. A systematic review of toxocariasis: a neglected but high-prevalence disease in Brazil. Am J Trop Med Hyg. 2016;94:1193–1199. doi:10.4269/ajtmh.15-0733

6. Smith H, Holland C, Taylor M, Magnaval JF, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182–188. doi:10.1016/j.pt.2009.01.006

7. Raissi V, Sohrabi Z, Getso M, et al. Risk factors and prevalence of toxocariasis in pregnant women and diabetic patients compared to healthy adults in Ilam Province, Western Iran. EXCLI J. 2018;17:983–988. doi:10.17179/excli2018-1630

8. Raissi V, Masoumi M, Ibrahim A, et al. Spatial analysis of Toxocara spp. eggs in soil as a potential for serious human infection. Comp Immunol Microbiol Inf Dis. 2021;75:101619. doi:10.1016/j.cimid.2021.101619

9. Zyoud SH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Res Policy Syst. 2017;15:14. doi:10.1186/s12961-017-0178-8

10. Chieffi PP, Santos SV, Queiroz ML, Lescano SA. Human toxocariasis: contribution by Brazilian researchers. Rev Inst Med Trop Sao Paulo. 2009;51:301–308. doi:10.1590/s0036-46652009000600001

11. Overgaauw PA. Aspects of Toxocara epidemiology: toxocarosis in dogs and cats. Crit Rev Microbiol. 1997;23:233–251. doi:10.3109/10408419709115138

12. Fava NMN, Cury MC, Santos HA, et al. Phylogenetic relationships among Toxocara spp. and Toxascaris sp. from different regions of the world. Vet Parasitol. 2020;282:109133. doi:10.1016/j.vetpar.2020.109133

13. Dantas-Torres F, Otranto D. Dogs, cats, parasites, and humans in Brazil: opening the black box. Parasit Vectors. 2014;7:22. doi:10.1186/1756-3305-7-22

14. Ramos DGS, Zocco BKA, Torres MM, Braga IA, Pacheco RC, Sinkoc AL. Helminths parasites of stray dogs (Canis lupus familiaris) from Cuiabá, Midwestern of Brazil. Semin Cienc Agrar. 2015;36:889–894. doi:10.5433/1679-0359.2015v36n2p889

15. Lima VF, Cringoli G, Rinaldi L, et al. A comparison of mini-FLOTAC and FLOTAC with classic methods to diagnosing intestinal parasites of dogs from Brazil. Parasitol Res. 2015;114:3529–3533. doi:10.1007/s00436-015-4605-x

16. Regis SC, Mendonça LR, Silva Ndos S, Dattoli VC, Alcântara-Neves NM, Barrouin-Melo SM. Seroprevalence and risk factors for canine toxocariasis by detection of specific IgG as a marker of infection in dogs from Salvador, Brazil. Acta Trop. 2011;120:46–51. doi:10.1016/j.actatropica.2011.05.011

17. Merigueti Y, Santarém VA, Ramires LM, et al. Protective and risk factors associated with the presence of Toxocara spp. eggs in dog hair. Vet Parasitol. 2017;244:39–43. doi:10.1016/j.vetpar.2017.07.020

18. Manini MP, Marchioro AA, Colli CM, Nishi L, Falavigna-Guilherme AL. Association between contamination of public squares and seropositivity for Toxocara spp. in children. Vet Parasitol. 2012;188:48–52. doi:10.1016/j.vetpar.201203.011

19. Santarém VA, Pereira VC, Alegre BC. Contamination of public parks in Presidente Prudente (São Paulo, Brazil) by Toxocara spp. eggs. Rev Bras Parasitol Vet. 2012;3:323–325. doi:10.1590/S1984-29612012000300029

20. Marques JP, Guimarães CR, Boas AV, Carnaúba PU, Moraes J. Contamination of public parks and squares from Guarulhos (São Paulo State, Brazil) by Toxocara spp. and Ancylostoma spp. Rev Inst Med Trop Sao Paulo. 2012;54:267–271. doi:10.1590/S0036-466.520120005500006

21. Ribeiro LM, Dracz RM, Mozzer LR, Lima WDS. Soil contamination in public squares in Belo Horizonte, Minas Gerais, by canine parasites in different developmental stages. Rev Inst Med Trop Sao Paulo. 2013;55:229–231. doi:10.1590/S0036-46652013000400002

22. Sprenger LK, Green KT, Molento MB. Geohelminth contamination of public areas and epidemiological risk factors in Curitiba, Brazil. Rev Bras Parasitol Vet. 2014;23:69–73. doi:10.1590/S1984-29612014009

23. Capella GDA, Pinto NB, Perera SC, et al. Environmental contamination by parasitic forms in a socially vulnerable community in southern Rio Grande do Sul state: a serious public health problem. Braz J Vet Res Anim Sci. 2018;55:1–8e132007. doi:10.11606/issn.1678-4456.bjvras.2018.132007

24. Mello CCS, Nizoli LQ, Ferraz A, Chagas BC, Azario WJD, Villela MM. Helminth eggs with zoonotic potential in the vicinity of public schools in southern Brazil. Rev Bras Parasitol Vet. 2020;29(1):e016419. doi:10.1590/S1984-29612019102

25. Leon IF, Strothmann AL, Islabão CL, Jeske S, Villela MM. Geohelminths in the soil of the Laguna dos Patos in Rio Grande do Sul state, Brazil. Braz J Biol. 2020;80:839–843. doi:10.1590/15196984.222590

26. Queiroz ML, Viel TA, Papa CH, Lescano SA, Chieffi PP. Behavioral changes in Rattus norvegicus coinfected by Toxocara canis and Toxoplasma gondii. Rev Inst Med Trop Sao Paulo. 2013;55:51–53. doi:10.1590/s0036-46652013000100009

27. Colli CM, Rubinsky-Elefant G, Paludo ML, et al. Serological, clinical and epidemiological evaluation of toxocariasis in urban areas of south Brazil. Rev Inst Med Trop Sao Paulo. 2010;52:69–74. doi:10.1590/S0036-46652010000200002

28. Dattoli VC, Freire SM, Mendonça LR, Santos PC, Meyer R, Alcantara-Neves NM. Toxocara canis infection is associated with eosinophilia and total IgE in blood donors from a large Brazilian centre. Trop Med Int Health. 2011;16:514–517. doi:10.1111/j.1365-3156.2010.02719.x

29. Souza RF, Dattoli VC, Mendonça LR, et al. [Prevalence and risk factors of human infection by Toxocara canis in Salvador, State of Bahia, Brazil]. Rev Soc Bras Med Trop. 2011;44::516–519. doi:10.1590/S0037-86822011000400024

30. Prestes-Carneiro LE, Rubinsky-Elefant G, Ferreira AW, et al. Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil. Pathog Glob Health. 2013;107:88–95. doi:10.1179/2047773213Y.0000000079

31. Negri EC, Santarém VA, Rubinsky-Elefant G, Giuffrida R. AntiToxocara spp. antibodies in an adult healthy population: serosurvey and risk factors in Southeast Brazil. Asian Pac J Trop Biomed. 2013;3:211–216. doi:10.1016/S2221-1691(13)60052-0

32. Santos PC, Lehmann LM, Lorenzi C, et al. The seropositivity of Toxocara spp. antibodies in pregnant women attended at the university hospital in southern Brazil and the factors associated with infection. PLoS One. 2015;10:e0131058. doi:10.1371/journal.pone.0131058

33. Pereira LC, Elefant GR, Nóbrega YM, et al. Toxocara spp. seroprevalence in pregnant women in Brasília, Brazil. Rev Soc Bras Med Trop. 2016;49:641–643. doi:10.1590/0037-8682-0106-2016

34. Araújo AC, Villela MM, Sena-Lopes A, et al. Seroprevalence of Toxoplasma gondii and Toxocara canis in a human rural population of Southern Rio Grande do Sul. Rev Inst Med Trop Sao Paulo. 2018;60:e28. doi:10.1590/s1678-9946201860028

35. Correa CR, Bismarck CM. Toxocariasis: incidence, prevalence and the time serum remains positive in school children from Campinas, SP, Brazil. J Trop Pediatr. 2010;56:215–216. doi:10.1093/tropej/fmp095

36. Santarém VA, Leli FN, Rubinsky-Elefant G, Giuffrida R. Protective and risk factors for toxocariasis in children from two different social classes of Brazil. Rev Inst Med Trop Sao Paulo. 2011;53:67–72. doi:10.1590/s0036-46652011000200002

37. Fragoso RP, Monteiro MB, Lemos EM, Pereira FE. Anti-Toxocara antibodies detected in children attending elementary school in Vitoria, State of Espírito Santo, Brazil: prevalence and associated factors. Rev Soc Bras Med Trop. 2011;44:461–466. doi:10.1590/s003786822011000400012

38. Marchioro AA, Colli CM, Mattia S, et al. Avaliação eosinofílica e soropositividade para anticorpos IgG anti-Toxocara em crianças atendidas pelo Sistema Único de Saúde [Eosinophilic count and seropositivity for IgG antibodies to Toxocara  spp. in chidren assisted at the public health service. 52 - Clinical and ultrasound liver impairment in children with toxocariasis]. Rev Paul Pediatr. 2011;29:80–84. doi:10.1590/S0103-05822011000100013

39. Mattia S, Colli CM, Adami CM, et al. Seroprevalence of Toxocara infection in children and environmental contamination of urban areas in Paraná State, Brazil. J Helminthol. 2012;86:440–445. doi:10.1017/S0022149X11000666

40. Mendonça LR, Figueiredo CA, Esquivel R, et al. Seroprevalence and risk factors for Toxocara infection in children from an urban large setting in Northeast Brazil. Acta Trop. 2013;128:90–95. doi:10.1016/j.actatropica.2013.06.018

41. Guilherme EV, Marchioro AA, Araujo SM, et al. Toxocariasis in children attending a public health service pneumology unit in Paraná State, Brazil. Rev Inst Med Trop Sao Paulo. 2013;55:189–192. doi:10.1590/s0036-46652013000300009

42. Schoenardie ER, Scaini CJ, Brod CS, et al. Seroprevalence of Toxocara infection in children from southern Brazil. J Parasitol. 2013;99:537–539. doi:10.1645/ge-3182

43. Oliart-Guzmán H, Delfino BM, Martins AC, et al. Epidemiology and control of child toxocariasis in the western Brazilian Amazon - a population-based study. Am J Trop Med Hyg. 2014;90:670–681. doi:10.4269/ajtmh.13-0506

44. Cassenote AJ, Lima AR, Pinto Neto JM, Rubinsky-Elefant G. Seroprevalence and modifiable risk factors for Toxocara spp. in Brazilian school children. PLoS Negl Trop Dis. 2014;8:e2830. doi:10.1371/journal.pntd.0002830

45. Marchioro AA, Colli CM, Ferreira EC, Viol BM, Araújo SM, Falavigna-Guilherme AL. Risk factors associated with toxoplasmosis and toxocariasis in populations of children from nine cities in southern Brazil. J Helminthol. 2015;89:428–432. doi:10.1017/s0022149x14000212

46. Silva MB, Amor ALM, Santos LN, et al. Risk factors for Toxocara spp. seroprevalence and its association with atopy and asthma phenotypes in school-age children in a small town and semi-rural areas of Northeast Brazil. Acta Trop. 2017;174:158–164. doi:10.1016/j.actatropica.2016.04.005

47. Araújo GMS, Walcher DL, Previtali IF, et al. Frequency of enteroparasitic infections and serum positivity for Toxocara spp. in children from a public day care center in southern Brazil. Braz J Biol. 2020;80:305–310. doi:10.1590/1519-6984.200952

48. Santos PC, Telmo PL, Lehmann LM, et al. Risk and other factors associated with toxoplasmosis and toxocariasis in pregnant women from southern Brazil. J Helminthol. 2017a;91:534–538. doi:10.1017/s0022149x16000481

49. Santos PC, Telmo PL, Lehmann LM, et al. Frequency of Toxocara spp. antibodies in umbilical cords of newborns attended at the University Hospital in Southern Brazil and factors associated with infection. Acta Trop. 2017b;170:43–47. doi:10.1016/j.actatropica.2017.02.003

50. Mattos GT, Santos PC, Telmo PL, Berne ME, Scaini CJ. Human toxocariasis: prevalence and factors associated with biosafety in research laboratories. Am J Trop Med Hyg. 2016;95:1428–1431. doi:10.4269/ajtmh.16-0196

51. Mendonça LR, Veiga RV, Dattoli VC, et al. Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American. PLoS Negl Trop Dis. 2012;6:e1886. doi:10.1371/journal.pntd.0001886

52. Carvalho EAA, Lunardi Rocha R, Pinto da silva RA. Comprometimento hepático clínico e ultrassonográfico em crianças com toxocaríase. Rev Med Minas Gerais. 2015;25:523–528. doi:10.5935/2238-3182.20150117

53. Zaia MG, Oliveira SR, Castro CA, et al. Toxocara canis and the allergic process. Mem Inst Oswaldo Cruz. 2015;110:726–731. doi:10.1590/0074-02760150051

54. Silva DCCE, Medeiros YRC, Kametani EI, et al. Loeffler syndrome in the differential diagnosis of severe asthma. Pediatr Pulmonol. 2016;51(S42):S59–S60. doi:10.1002/ppul.23409

55. Grama DF, Lescano SZ, Pereira Mota KC, et al. Seroprevalence of Toxocara spp. in children with atopy. Trans R Soc Trop Med Hyg. 2014;108:797–803. doi:10.1093/trstmh/tru165

56. Cadore PS, Zhang L, Lemos Lde L, et al. Toxocariasis and childhood asthma: a case-control study. J Asthma. 2016;53:601–606. doi:10.3109/02770903.2015.1064951

57. Fialho PM, Corrêa CRS. Toxocaríase, asma e índice de massa corporal em crianças e adolescentes em Campinas-SP, 1996 a 1998. Epidemiol Serv Saúde[Toxocariasis, asthma and body mass index in children and adolescent in Campinas, São Paulo State, Brazil, 1996-1998. 79 - Ultrasonographic findings in ocular toxocariasis]. 2014;23:361–368. doi:10.5123/S1679-49742014000200018

58. Fialho PM, Correa CRS, Lescano SZ. Asthma and seroconversion from Toxocara spp. infection: which comes first? Biomed Res Int. 2018;2018:4280792. doi:10.1155/2018/4280792

59. Fialho PM, Correa CRS, Lescano SZ. Seroprevalence of toxocariasis in children with urticaria: a population-based study. J Trop Pediatr. 2017;63:352–357. doi:10.1093/tropej/fmw094

60. Recuero JK, Binda G, Kiszewski AE. Eosinophilic panniculitis associated with toxocariasis in a child. An Bras Dermatol. 2019;94:243–254. doi:10.1590/abd1806-4841.20198172

61. Salvador S, Ribeiro R, Winckler MI, Ohlweiler L, Riesgo R. Pediatric neurotoxocariasis with concomitant cerebral, cerebellar, and peripheral nervous system involvement: case report and review of the literature. J Pediatr (Rio J). 2010;86:531–534. doi:10.2223/jped.2037

62. Viola GR, Giacomin MF, França CM, Sallum AM, Jacob CM, Silva CA. Chronic polyarthritis as isolated manifestation of toxocariasis. Rev Bras Reumatol. 2016;56:185–187. doi:10.1016/j.rbre.2014.07.005

63. Brito T, Chieffi PP, Peres BA, et al. Immunohistochemical detection of toxocaral antigens in human liver biopsies. Int J Surg Pathol. 1994;2:117–124. doi:10.1177/106689699400200206

64. Moreira GM, Telmo Pde L, Mendonça M, et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014;30:456–464. doi:10.1016/j.pt.2014.07.003

65. Felicetti CPD, Sinnott F, Monte LG, et al. Diagnostic potential of AntiRTE30 polyclonal antibodies In a blocking Elisa for Toxocara canis detection. J Parasitol. 2019;105:64–68. doi:10.1645/17-59

66. Rubinsky-Elefant G, Hoshino-Shimizu S, Jacob CM, Sanchez MC, Ferreira AW. Potential immunological markers for diagnosis and therapeutic assessment of toxocariasis. Rev Inst Med Trop Sao Paulo. 2011;53:61–65. doi:10.1590/s0036-46652011000200001

67. Peixoto PL, Nascimento E, Cançado GG, et al. Identification of candidate antigens from adult stages of Toxocara canis for the serodiagnosis of human toxocariasis. Mem Inst Oswaldo Cruz. 2011;106:200–206. doi:10.1590/s0074-02762011000200014

68. Carvalho EA, Rocha RL. Visceral larva migrans syndromes associated with toxocariasis: epidemiology, clinical and laboratory aspects of human toxocariasis. Curr Trop Med Rep. 2014;1:74–79. doi:10.1007/s40475-013-0011-6

69. Zhan B, Ajmera R, Geiger SM, et al. Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis. Trop Med Int Health. 2015;20:1787–1796. doi:10.1111/tmi.12607

70. Roldán WH, Elefant GR, Ferreira AW. Deglycosylation of Toxocara excretory-secretory antigens improves the specificity of the serodiagnosis for human toxocariasis. Parasite Immunol. 2015;37:557–567. doi:10.1111/pim.12248

71. Roldán WH, Elefant GR, Ferreira AW. Immunoglobulin M antibodies are not specific for serodiagnosis of human toxocariasis. Parasite Immunol. 2017;39:e12447. doi:10.1111/pim.12447

72. Santos LMD, Cerqueira MP, Gaboardi GC, et al. Evaluation of Toxocara canis glycosylated TES produced in Pichia pastoris for immunodiagnosis of human toxocariasis. Braz Arch Biol Technol. 2020;63:e20190148. doi:10.1590/1678-4324-2020190148

73. Santos LMD, Magalhães CG, Telmo PL, et al. Sensitivity and specificity of recombinant proteins in Toxocara spp. for serodiagnosis in humans: differences in adult and child populations. PLoS One. 2018;13:e0208991. doi:10.1371/journal.pone.0208991

74. Sperotto RL, Kremer FS, Aires berne ME, et al. Proteomic analysis of Toxocara canis excretory and secretory (TES) proteins. Mol Biochem Parasitol. 2017;211:39–47. doi:10.1016/j.molbiopara.2016.09.002

75. Silva MB, Urrego AJ, Oviedo Y, et al. The somatic proteins of Toxocara canis larvae and excretory-secretory products revealed by proteomics. Vet Parasitol. 2018;259:25–34. doi:10.1016/j.vetpar.2018.06.015

76. Rubinsky-Elefant G, Yamamoto JH, Hirata CE, Prestes-Carneiro LE. Toxocariasis: critical analysis of serology in patients attending a public referral center for ophthalmology in Brazil. Jpn J Ophthalmol. 2018;62:77–83. doi:10.1007/s10384-017-0543-8

77. Souto FMS, Giampietro BV, Takiuti JT, Campos LMA, Hirata CE, Yamamoto JH. Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil. Br J Ophthalmol. 2019;103:636–640. doi:10.1136/bjophthalmol-2018-312313

78. Lago A, Andrade R, Muccioli C, Belfort R Jr. Optical coherence tomography in presumed subretinal Toxocara granuloma: case report. Arq Bras Oftalmol. 2006;69:403–405. doi:10.1590/s0004-27492006000300022

79. Morais FB, Maciel AL, Arantes TE, Muccioli C, Allemann N. Achados ultrassonográficos em toxocaríase ocular. Arq Bras Oftalmol. 2012;75:43–47. doi:10.1590/s0004-27492012000100009

80. Lescano SA, Nakhle MC, Ribeiro MC, Chieffi PP. IgG antibody responses in mice coinfected with Toxocara canis and other helminths or protozoan parasites. Rev Inst Med Trop Sao Paulo. 2012;54:145–152. doi:10.1590/s0036-46652012000300006

81. Schoenardie ER, Scaini CJ, Avila LF, et al. Determination of IgG avidity in BALB/c mice experimentally infected with Toxocara canis. Rev Bras Parasitol Vet. 2014;23:403–406. doi:10.1590/s1984-29612014060

82. Resende NM, Gazzinelli-Guimarães PH, Barbosa FS, et al. New insights into the immunopathology of early Toxocara canis infection in mice. Parasit Vectors. 2015;8:354. doi:10.1186/s13071-015-0962-7

83. Raposo RS, Santarém VA, Merigueti YF, et al. Kinetic and avidity of IgY anti-Toxocara antibodies in experimentally infected chickens. Exp Parasitol. 2016;171:33–41. doi:10.1016/j.exppara.2016.09.009

84. Bin LLC, Santarém VA, Laposy CB, Rubinsky-Elefant G, Roldán WH, Giuffrida R. Kinetics and avidity of anti-Toxocara antibodies (IgG) in rabbits experimentally infected with Toxocara canis. Bras J Vet Parasitol. 2016;25:99–104. doi:10.1590/S1984-29612015067

85. Fonseca GRE, Santos SVD, Chieffi PP, Paula FM, Gryschek RCB, Lescano SAZ. Experimental toxocariasis in BALB/c mice: relationship between parasite inoculum and the IgG immune response. Mem Inst Oswaldo Cruz. 2017;112:382–386. doi:10.1590/0074-02760160341

86. Rodolpho JMA, Camillo L, Araújo MSS, et al. Robust phenotypic activation of eosinophils during experimental Toxocara canis infection. Front Immunol. 2018;9:64. doi:10.3389/fimmu.2018.00064

87. Santos LMD, de Moura MQ, Azevedo ML, et al. Reactivity of recombinant Toxocara canis TES-30/120 in experimentally infected mice. Parasite Immunol. 2018;40:e12568. doi:10.1111/pim.12568

88. Moura MQ, Macedo MRP, Terto W, et al. Detection of Toxocara canis DNA in tissues of experimentally infected mice. Acta Trop. 2018;187:51–56. doi:10.1016/j.actatropica.2018.07.017

89. Moura MQ, Terto W, Avila L, et al. Quantification of Toxocara canis DNA by qPCR in mice inoculated with different infective doses. Parasitol Int. 2020;78:102134. doi:10.1016/j.parint.2020.102134

90. Garcés LFS, Santiago LF, Santos SPO, et al. Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis. Vaccine. 2020;38:4762–4772. doi:10.1016/j.vaccine.2020.04.072

91. Rassier GL, Borsuk S, Pappen F, et al. Toxocara spp. seroprevalence in sheep from southern Brazil. Parasitol Res. 2013;112:3181–3186. doi:10.1007/s00436-013-3499-8

92. Dutra GF, Pinto NS, De avila LF, et al. Risk of infection by the consumption of liver of chickens inoculated with low doses of Toxocara canis eggs. Vet Parasitol. 2014;203:87–90. doi:10.1016/j.vetpar.2014.03.025

93. Campos-da-silva DR, da Paz JS, Fortunato VR, Beltrame MA, Valli LC, Pereira FE. Natural infection of free-range chickens with the ascarid nematode Toxocara sp. Parasitol Res. 2015;114:4289–4293. doi:10.1007/s00436-015-4669-7

94. Oliveira AC, Rubinsky-Elefant G, Merigueti Y, Batista ADS, Santarém VA. Frequency of anti-Toxocara antibodies in broiler chickens in southern Brazil. Rev Bras Parasitol Vet. 2018;27:141–145. doi:10.1590/s1984-296120180025

95. Santos LMD, Donassolo RA, Berne ME, et al. The serodiagnostic potential of recombinant proteins TES-30 and TES-120 in an indirect ELISA in the diagnosis of toxocariasis in cattle, horses, and sheep. PLoS One. 2019;14:e0213830. doi:10.1371/journal.pone.0213830

96. Magnaval JF, Gligman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1–11. doi:10.3347/kjp.2001.39.1.1

97. Lescano SA, Santos SV, Assis JM, Chieffi PP. Efficacy of nitazoxanide against Toxocara canis: larval recovery and humoral immune response in experimentally infected mice. Rev Inst Med Trop Sao Paulo. 2015;57:337–341. doi:10.1590/s0036-46652015000400011

98. Mata-Santos T, Pinto NF, Mata-Santos HA, et al. Anthelmintic activity of lapachol, β-lapachone and its derivatives against Toxocara canis larvae. Rev Inst Med Trop Sao Paulo. 2015;57:197–204. doi:10.1590/s0036-46652015000300003

99. Mata-Santos T, Mata-Santos HA, Carneiro PF, et al. Toxocara canis: anthelmintic activity of quinone derivatives in murine toxocarosis. Parasitology. 2016;143:507–517. doi:10.1017/s0031182016000068

100. Sinott FA, Sena-Lopes A, Leal KS, et al. Essential oil from Brazilian Red Propolis exhibits anthelmintic activity against larvae of Toxocara cati. Exp Parasitol. 2019;200:37–41. doi:10.1016/j.exppara.2019.03.014xz

101. Avila LFC, Da Fonseca JS, Dutra GF, et al. Evaluation of the immunosuppressive effect of cyclophosphamide and dexamethasone in mice with visceral toxocariasis. Parasitol Res. 2012;110:443–447. doi:10.1007/s00436-011-2510-5

102. Avila LFC, Conceição FR, Telmo PL, et al. Saccharomyces boulardii reduces infection intensity of mice with toxocariasis. Vet Parasitol. 2012;187:337–340. doi:10.1016/j.vetpar.2012.01.002

103. Avila LF, Telmo Pde L, Martins LH, et al. Protective effect of the probiotic Saccharomyces boulardii in Toxocara canis infection is not due to direct action on the larvae. Rev Inst Med Trop Sao Paulo. 2013;55:363–365. doi:10.1590/s0036-46652013000500012

104. Avila LFC, De leon PM, De moura MQ, Berne ME, Scaini CJ, Leivas Leite FP. Modulation of IL-12 and IFNγ by probiotic supplementation promotes protection against Toxocara canis infection in mice. Parasite Immunol. 2016;38:326–330. doi:10.1111/pim.12314

105. Moura MQ, Da silva terto WD, Jeske ST, et al. Evaluation of the transcription of interleukin-12 in the intestinal mucosa of mice subjected to experimental toxocariasis and supplemented with Saccharomyces boulardii. Vet Parasitol. 2017;242:59–62. doi:10.1016/j.vetpar.2017.05.012

106. Walcher DL, Cruz LAX, De lima Telmo P, et al. Lactobacillus rhamnosus reduces parasite load on Toxocara canis experimental infection in mice, but has no effect on the parasite in vitro. Parasitol Res. 2018;117:597–602. doi:10.1007/s00436-017-5712-7

107. Braga FR, Ferreira SR, Araújo JV, et al. Predatory activity of Pochonia chlamydosporia fungus on Toxocara (syn. Neoascaris) vitulorum eggs. Trop Anim Health Prod. 2010;42:309–314. doi:10.1007/s11250-009-9422-8

108. Carvalho RO, Araújo JV, Braga FR, Araujo JM, Alves CD. Ovicidal activity of Pochonia chlamydosporia and Paecilomyces lilacinus on Toxocara canis eggs. Vet Parasitol. 2010;169:123–127. doi:10.1016/j.vetpar.2009.12.037

109. Hiura E, Del Carmen Garcia Lopes A, da Paz JS, et al. Fungi predatory activity on embryonated Toxocara canis eggs inoculated in domestic chickens (Gallus gallus domesticus) and destruction of second stage larvae. Parasitol Res. 2015;114:3301–3308. doi:10.1007/s00436-015-4553-5

110. Maia Filho FS, Fonseca AOS, Persici BM, et al. Trichoderma virens as a biocontrol of Toxocara canis: in vivo evaluation. Rev Iberoam Micol. 2017;34:32–35. doi:10.1016/j.riam.2016.06.004

111. Maia Filho FS, Nunes Vieira J, Aires Berne ME, et al. Fungal ovicidal activity on Toxocara canis eggs. Rev Iberoam Micol. 2013;30:226–230. doi:10.1016/j.riam.2012.12.009

112. Verocai GG, Tavares PV, De A. ribeiro F, Correia TR, Scott FB. Effects of disinfectants on Toxocara canis embryogenesis and larval establishment in mice tissues. Zoonoses Public Health. 2010;57:e213–6. doi:10.1111/j.1863-2378.2010.01330.x

113. Merigueti Y, da Silva Raposo R, Zampieri BP, de Lima Cerazo LM, Pereira L, Santarém VA. Dispersion and infectivity of Toxocara canis eggs after passage through chicken intestine. Parasitol Res. 2018;117:3481–3486. doi:10.1007/s00436-018-6045-x

114. von Sohsten AL, Vieira da Silva A, Rubinsky-Elefant G, et al. Chickens bred extensively as sentinels from soil contamination by Toxocara. Exp Parasitol. 2020;211:107852. doi:10.1016/j.exppara.2020.107852

115. Aguiar PS, Furtado RD, de Avila LF, et al. Transmammary infection in BALB/c mice with chronic toxocariasis. Parasitol Int. 2015;64:145–147. doi:10.1016/j.parint.2014.04.010

116. Telmo PL, Avila LF, Santos CA, et al. Elevated trans-mammary transmission of Toxocara canis larvae in BALB/c mice. Rev Inst Med Trop Sao Paulo. 2015;57:85–87. doi:10.1590/s0036-46652015000100013

117. Santos SV, Yazawa santos FH, Zevallos lescano SA, et al. Migration pattern of Toxocara canis larvae in experimentally infected male and female Rattus norvegicus. Rev Soc Bras Med Trop. 2017;50:698–700. doi:10.1590/0037-8682-0076-2017

118. Flecher MC, Musso C, Martins IV, Pereira FE. Larval migration of the ascarid nematode Toxocara canis following infection and re-infection in the gerbil Meriones unguiculatus. J Helminthol. 2016;90:569–576. doi:10.1017/s0022149x15000760

119. Cox DM, Holland CV. The influence of mouse strain, infective dose and larval burden in the brain on activity in Toxocara-infected mice. J Helminthol. 2001a;75:23–32. doi:10.1079/JOH200027

120. Cox DM, Holland CV. Relationship between three intensity levels of Toxocara canis larvae in the brain effects on exploration, anxiety, learning and memory in the murine host. J Helminthol. 2001b;75:33–41. doi:10.1079/JOH200028

121. Santos SV, Moura JV, Lescano SA, Castro JM, Ribeiro MC, Chieffi PP. Behavioural changes and muscle strength in Rattus norvegicus experimentally infected with Toxocara cati and T. canis. J Helminthol. 2015;89:465–470. doi:10.1017/s0022149x14000303

122. Corrêa FM, Chieffi PP, Lescano SA, Santos SV. Behavioral and memory changes in Mus musculus coinfected by Toxocara canis and Toxoplasma gondii. Rev Inst Med Trop Sao Paulo. 2014;56:353–356. doi:10.1590/s0036-46652014000400014

123. Silva AM, Chieffi PP, Da silva WL, et al. The hamster (Mesocricetus auratus) as an experimental model of toxocariasis: histopathological, immunohistochemical, and immunoelectron microscopic findings. Parasitol Res. 2015;114:809–821. doi:10.1007/s00436-014-4246-5

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.